Study on the Mechanism of Compound
Longxuejie Capsules in Treating Coronary Heart Disease Based on Network
Pharmacology and Molecular Docking

Abstract

Abstract: Objective： To explore the mechanism of Compound Longxuejie Capsules in treating coronary heart disease by network pharmacology and molecular docking. Methods： The chemical components of Compound Longxuejie Capsules were searched by Traditional Chinese Medicine Systems Pharmacology database； SwissADME platform and Swiss Target Prediction database were used to screen active components and obtain drug targets； disease targets were obtained from GeneCards and other databases； drug-component-disease target network and the protein-protein interaction network were constructed； GO analysis and KEGG pathway enrichment analysis were conducted through Metascape platform； AutodockVina software was used to dock the active components with the key targets. Results： 81 active components were screened. 124 targets were related to coronary heart disease， and the key targets were AKT1， EGFR， AR， PTGS2， SRC and ESR1. GO analysis and KEGG pathway enrichment analysis showed that the targets involved nuclear factor-κB， PPAR and other signaling pathways， and biological processes such as inflammation reaction and fatty acid metabolism. The results of molecular docking showed that the binding activity of the active component to the key targets was strong. Conclusion： It is predicted that quercetin， resveratrol and other active components in Compound Longxuejie Capsules will combine with AKT1， AR， PTGS2 and other targets to act on nuclear factor-κB， PPAR and other signal pathways， which play a role in treating coronary heart disease.

Key words: font-family:Times New Roman, ">Compound Longxuejie Capsulesfont-family:Times New Roman, ">, font-family:Times New Roman, "> coronary heart diseasefont-family:Times New Roman, ">, font-family:Times New Roman, "> network pharmacologyfont-family:Times New Roman, ">, font-family:Times New Roman, "> molecular dockingfont-family:Times New Roman, ">, font-family:Times New Roman, "> mechanism

CLC Number:

Zhu Qianwei, Yang Hua, Qian Kai, Li Dan, Xia Conglong.

Study on the Mechanism of Compound Longxuejie Capsules in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking [J]. Journal of Dali University, 2023, 8(2): 8-18.

References

〔1〕中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要〔J〕. 中国循环杂志， 2022， 37（6）： 553-578.

〔2〕汪进洋，刘明涛. 2016—2020年东营市东营区20岁及以上居民冠心病发病率变化趋势及类型分析〔J〕. 预防医学论坛， 2022， 28（7）： 526-529.

〔3〕冯春前. 药物治疗老年冠心病的研究进展〔J〕. 中西医结合心血管病电子杂志， 2021， 9（9）： 15-17.

〔4〕 DING M， MA W， WANG X， et al. A Network Pharmacology Integrated Pharmacokinetics Strategy for Uncovering Pharmacological Mechanism of Compounds Absorbed into the Blood of Dan-Lou Tablet on Coronary Heart Disease〔J〕. J Ethnopharmacol，2019，242：112055.

〔5〕 LI D， LIU L， YANG S， et al. Exploring the Therapeutic Mechanisms of Huzhang-Shanzha Herb Pair against Coronary Heart Disease by Network Pharmacology and Molecular Docking〔J〕. Evid Based Complement Alternat Med， 2021， 2021： 5569666.

〔6〕杨颖，毕颖斐，王贤良，等. 中成药分型论治冠心病心绞痛临床研究进展〔J〕. 天津药学， 2020， 32（3）： 55-58.

〔7〕《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗冠心病临床应用指南（2020年）〔J〕. 中国中西医结合杂志， 2021， 41（4）： 391-417.

〔8〕张丽，王绪平，黄孝闻，等. 血竭及龙血竭化学成分、药理作用研究进展〔J〕. 中国现代应用药学，2019，36（20）： 2605-2611.

〔9〕蔡琳，彭鹏.三七药理作用的研究进展〔J〕. 山东化工， 2021，

50（3）： 70-71.

〔10〕李维，艾芬，陈阵. 复方龙血竭胶囊与复方丹参胶囊治疗稳定性心绞痛临床疗效比较〔J〕. 世界中西医结合杂志， 2015， 10（8）： 1116-1118.

〔11〕江盈，李诗国，吕艳叶. 复方龙血竭胶囊治疗冠心病心绞痛70例〔J〕. 浙江中西医结合杂志，2015，25（6）： 593-

594.

〔12〕 YU Y D， HOU W J， ZHANG J， et al. Network Pharmacology and Molecular Docking-Based Analysis on Bioactive Anticoronary Heart Disease Compounds in Trichosanthes kirilowii Maxim and Bulbus allii Macrostemi〔J〕. Evid Based Complement Alternat Med， 2021， 2021： 6704798.

〔13〕 BI S， XU L， CHEN S， et al. Detection of Herbal Combinations and Pharmacological Mechanisms of Clinical Prescriptions for Coronary Heart Disease Using Data Mining and Network Pharmacology〔J〕. Evid Based Complement Alternat Med， 2021， 2021： 9234984.

〔14〕朱锐灵，沈悦，马飞鸿，等. 分子对接技术在中药抗炎活性成分筛选和作用机制研究中的应用〔J〕. 中国药理学与毒理学杂志， 2018， 32（6）： 497-506.

〔15〕 XU H Y， ZHANG Y Q， LIU Z M， et al. ETCM： An Encyclopaedia of Traditional Chinese Medicine〔J〕. Nucleic Acids Res， 2019， 47（D1）： D976-D982.

〔16〕 DAINA A， MICHIELIN O， ZOETE V. SwissADME： A Free Web Tool to Evaluate Pharmacokinetics， Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules〔J〕. Sci Rep， 2017， 7： 42717.

〔17〕 DAINA A， MICHIELIN O， ZOETE V. SwissTarget- Prediction： Updated Data and New Features for Efficient Prediction of Protein Targets of Small Molecules〔J〕. Nucleic Acids Res， 2019， 47（W1）：W357-W364.

〔18〕 SAFRAN M， DALAH I， ALEXANDERL J， et al. GeneCards Version 3： The Human Gene Integrator〔J〕. Database （Oxford）， 2010， 2010： baq020.

〔19〕 PI?譙ERO J， BRAVO ?魥， QUERALT-ROSINACH N， et al.

DisGeNET： A Comprehensive Platform Integrating Infor-mation on Human Disease-Associated Genes and Variants〔J〕. Nucleic Acids Res， 2016， 45（D1）： D833-D839.

〔20〕 ZHOU Y， ZHANG Y， LIAN X， et al. Therapeutic Target Database Update 2022： Facilitating Drug Discovery with Enriched Comparative Data of Targeted Agents〔J〕. Nucleic Acids Res， 2022， 50（D1）： D1398-D1407.

〔21〕 WISHART D S， FEUNANG Y D， GUO A C， et al. DrugBank 5.0： A Major Update to the DrugBank Database for 2018〔J〕. Nucleic Acids Res，2018，46（D1）：

D1074-D1082.

〔22〕 SZKLARCZYK D， GABLE A L， NASTOU K C， et al. The STRING Database in 2021： Customizable Protein-Protein Networks， and Functional Characterization of User-Uploaded Gene/Measurement Sets〔J〕. Nucleic Acids

Res， 2021， 49（D1）： D605-D612.

〔23〕 ZHOU Y， ZHOU B， PACHE L， et al. Metascape Provides a Biologist-Oriented Resource for the Analysis of Systems-Level Datasets〔J〕. Nat Commun， 2019， 10（1）：1523.

〔24〕 KIM S， CHEN J， CHENG T， et al. PubChem in 2021： New Data Content and Improved Web Interfaces〔J〕. Nucleic Acids Res， 2021， 49（D1）： D1388-D1395.

〔25〕 BURLEY S K， BHIKADIYA C， BI C， et al. RCSB Protein Data Bank： Powerful New Tools for Exploring 3D Structures of Biological Macromolecules for Basic and Applied Research and Education in Fundamental Biology， Biomedicine， Biotechnology， Bioengineering and Energy Sciences〔J〕. Nucleic Acids Res， 2021， 49（D1）： D437-D451.

〔26〕 MUSCELLA A， STEFANO E， MARSIGLIANTE S. The Effects of Exercise Training on Lipid Metabolism and Coronary Heart Disease〔J〕. Am J Physiol Heart Circ Physiol， 2020， 319（1）： H76-H88.

〔27〕 FR■K W， WOJTASI SKA A， LISI SKA W， et al. Pathophysiology of Cardiovascular Diseases： New Insights into Molecular Mechanisms of Atherosclerosis， Arterial Hypertension， and Coronary Artery Disease〔J〕. Biomedicines， 2022， 10（8）： 1938.

〔28〕 ZHENG X， ZHU S， CHANG S， et al. Protective Effects of Chronic Resveratrol Treatment on Vascular Inflammatory Injury in Streptozotocin-Induced Type 2 Diabetic Rats： Role of NF-Kappa B signaling〔J〕. Eur J Pharmacol， 2013， 720（1-3）： 147-157.

〔29〕 GHOLAMI M， KHAYAT Z K， ANBARI K， et al. Quercetin Ameliorates Peripheral Nerve Ischemia-Reper-fusion Injury through the NF-Kappa B Pathway〔J〕. Anat Sci Int， 2017， 92（3）： 330-337.

〔30〕 MIRZA A Z， ALTHAGAFI I I， SHAMAHAD H. Role of PPAR Receptor in Different Diseases and Their Ligands： Physiological Importance and Clinical Implications〔J〕. Eur J Med Chem， 2019， 166： 502-513.

〔31〕 LAMAS B M， FERREIRA A M. Understanding Peroxisome Proliferator-Activated Receptors： From the Structure to the Regulatory Actions on Metabolism〔J〕. Adv Exp Med Biol， 2019， 1127： 39-57.

〔32〕 CARRIZZO A， IZZO C， FORTE M， et al. A Novel Promising Frontier for Human Health： The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases〔J〕. Int J Mol Sci， 2020， 21（22）： 8706.

〔33〕 TESTAI L， CALDERONE V. Nutraceutical Value of Citrus Flavanones and Their Implications in Cardio-vascular Disease〔J〕. Nutrients， 2017， 9（5）： 502.

〔34〕 ZAIDUN N H， THENT Z C， LATIFF A A. Combating Oxidative Stress Disorders with Citrus Flavonoid： Naringenin〔J〕. Life Sci，2018， 208： 111-122.

〔35〕 ULLAH R， ALI G， RASHEED A， et al. The 7-Hydroxyflavone Attenuates Chemotherapy-Induced Neu-ropathic Pain by Targeting Inflammatory Pathway〔J〕. Int Immunopharmacol， 2022， 107：108674.

[1]	Ma Yongjie, Li Weiqi, Wu Chunting, Huang Xinhui, Zhou Xinyu, Ya Fuli, . The Protective Effect and Mechanism of Panax notoginseng Saponins on ox-LDL-Induced Platelet Apoptosis [J]. Journal of Dali University, 2023, 8(2): 1-7.
[2]	He Siyue, Tang Ziyun, Liu Heng, Zhang Chenggui, Zhou Wen, Bi Ziying, Zhou Yue. Inhibition of K562 Cell Proliferation by p53 Protein Regulated by Periplaneta americana Extract CⅡ-3 [J]. Journal of Dali University, 2023, 8(2): 19-23.
[3]	Li Weiqian, Chen Yiming, Zhang Wenting, Su Yingzhen, Shuai Hongyan, Yu Xin. Bioinformatics-Ｂased Analysis and Screening of Differentially Expressed Genes in Pancreatic Cancer [J]. Journal of Dali University, 2023, 8(2): 24-30.
[4]	Cheng Mingjing, Yan Ping, Fan Yujuan, Zhao Weidong. Bioinformatic Analysis of Differentially Expressed Genes in the Patients Infected with Helicobacter pylori [J]. Journal of Dali University, 2023, 8(2): 31-35.
[5]	Yao Qiuyan, Wu Zesheng, Shi Rognjie, Yang Liwei. Analysis of Short-Term Prognostic Factors in Alcoholic Liver Disease-Related Acute-on-Chronic Liver Failure [J]. Journal of Dali University, 2023, 8(2): 36-41.
[6]	Song Qiuling, Dai Jiao. The Expression of Serum Progranulin in Patients with Graves Disease and Its Correlation with IL-17 and IL-10 [J]. Journal of Dali University, 2023, 8(2): 42-45.
[7]	Cheng Wei, Shi Haibin, Cun Xiangnong, Ai Kewei, Fan Jiaju, Yang Jiwu. A Comparative Study of the Clinical Efficacy of Endoscopic Thyroidectomy via the Thoracic-Breast Approach and Open Thyroidectomy [J]. Journal of Dali University, 2023, 8(2): 46-50.
[8]	Chen Huaqiu, Chen Xingyou, Wang Guangming. Study of the Distribution of High-Risk Human Papilloma Virus Subtypes in Liangshan Region， Sichuan Province [J]. Journal of Dali University, 2023, 8(2): 51-55.
[9]	Tian Tian, Yan Jing, Dai Jiao. Changes of MiR-1281 and MiR-122 in Peripheral Blood of DR Patients and Their Relationship with the Severity of Retinopathy [J]. Journal of Dali University, 2023, 8(2): 56-61.
[10]	Sun Xiaomei, Mei Wen, He Bing, Luo Zhonggui, Sun Ruli, Xiong Wei, Zhao Yi. Expression and Prognostic Significance of Ki-67， Bcl-6， Bcl-2 and TEFM in Diffuse Large B Cell Lymphoma [J]. Journal of Dali University, 2023, 8(2): 62-69.
[11]	Xia Wangxu, He Yongfang, Chen Xiaobo, Huang Chuanfen. The Value of Quantitative CT in Bone Mineral Density Measurement of Patients with Chronic Kidney Disease [J]. Journal of Dali University, 2023, 8(2): 70-73.
[12]	Dong Liwen, Wang Caihong, Zou Tuanbiao. Comparison of Three Detection Methods for Urinary Sediment [J]. Journal of Dali University, 2023, 8(2): 74-77.
[13]	Ni Zhaolin, Zuo Shunwu, Liu Hongyan, Ai Zhiqiong, Nong Luming, Zhao Qiufang, Wu Qiang. Epidemiological Characteristics and Trend Prediction of Influenza in Yuxi City from 2010 to 2019 [J]. Journal of Dali University, 2023, 8(2): 78-83.
[14]	Miao Zhifei, Huang Zhaodan, Chen Yanqing, Chang Yanping. Application of Drawing the Vascular Site Map under B-Ultrasound in Rope Ladder Puncture [J]. Journal of Dali University, 2023, 8(2): 84-87.
[15]	Zhu Xiaoli, Shi Tingting, Zhang Likun, Wei Yanni, Li Ting, Zhang Xiaoling. Application Analysis of Individualized Follow-Up Guidance Based on Network Platform in Patients with Basal Insulin [J]. Journal of Dali University, 2023, 8(2): 88-92.

Study on the Mechanism of Compound Longxuejie Capsules in Treating Coronary Heart Disease Based on Network Pharmacology and Molecular Docking

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments